6
MERK0312.TXT

MERK
Merck Indonesia Tbk
Af          :
Sector Code : 53
Sector Name : PHARMACEUTICALS

(In thousand rupiah except Par Value, Closing Price and Ratios)

Financial Statement Date    : 31-Dec-2003
Fiscal Year Ends            : Dec
Months Covered in Income St : 12

Summary of Balance Sheet
  Receivables               :      48,915,420.00
  Inventories               :      49,579,067.00
  Current Assets            :     138,987,098.00
  Fixed Assets              :      45,773,339.00
  Other Asstes              :         996,349.00
  Total Assets              :     200,328,300.00
  Current Liabilities       :      40,122,287.00
  Longterm Liabiities       :         696,327.00
  Total Liabilities         :      40,818,614.00
  Authorized                :          22,400.00
  Paid-up Capital           :      22,400,000.00
  Par Value                 :               1000
  Paid-up Capital Shares    :          22,400.00
  Retained Earnings         :     118,238,692.00
  Total Equity              :     159,502,944.00
  Minority Interest         :           6,742.00

Summary of Income Statement
  Total Sales               :     296,320,208.00
  Cost of Good Sold         :     115,748,934.00
  Gross Profit              :     180,571,274.00
  Operating Profit          :      68,223,430.00
  Other Income              :       3,913,589.00
  Eearning Before Tax       :      72,137,019.00
  Tax                       :      21,552,635.00
  Net Income                :      50,580,140.00
  Closing Price             :          16,000.00

Per Share Data (Rp)
  Eps                       :           2,258.04
  Book Value                :           7,120.67

Financial Ratios
  Debt Equity Ratio (X)     :                .26
  Roa (%)                   :              25.25
  Roe (%)                   :              31.71
  Npm (%)                   :              17.07
  Opm (%)                   :              23.02

Cash Flow
  CF from Operating Activities                        :      64,477,144.00
  CF from Investing Activities                        :     -19,164,393.00
  CF from Financing Activities                        :     -47,039,124.00
  Net Increase in Cash & Cash Equivalent              :      -1,726,373.00
  Cash & Cash Equivalent at The Beginning of The Year :      38,559,853.00
  Cash & Cash Equivalent at The End of The Year       :      36,738,261.00

 
 
 
